Pharma and Biotech
Period Ending | Period | Revenue (£m) | Pre-tax (£m) | EPS | Dividend |
---|---|---|---|---|---|
30-Jun-24 | Interim | 84.08 | (71.36) | (9.00)p | n/a |
Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
---|---|---|---|---|---|---|---|---|
31-Dec-21 | 133.66 | (166.00) | 23.00p | 30.3 | n/a | n/a | n/a | 0.0% |
31-Dec-22 | 198.60 | (83.41) | (11.00)p | n/a | n/a | n/a | n/a | 0.0% |
31-Dec-23 | 169.67 | (149.77) | (19.00)p | n/a | n/a | n/a | n/a | 0.0% |
a. Based on UK GAAP presentation of accounts - includes discontinued activities
Forecasts data is not available for this company.
Copyright © 2024 FactSet Research Systems Inc. All rights reserved.
5 Yr High | 5 Yr Low | 5 Yr Avg | Curr / Avg | |
---|---|---|---|---|
Latest | 30.35 | 30.35 | n/a | 0 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 154.80p |
Change Today | -0.20p |
% Change | -0.13 % |
52 Week High | 208.20 |
52 Week Low | 86.55 |
Volume | 1,745,118 |
Shares Issued | 954.91m |
Market Cap | £1,478.21m |
Beta | 1.26 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:47 | 39,160 @ 154.10p |
16:35 | 740,382 @ 154.80p |
16:35 | 946 @ 154.80p |
16:35 | 4,414 @ 154.80p |
16:35 | 6,448 @ 154.80p |
CEO | Gurdial (Gordon) Sanghera |
CFO | Nick Keher |
You are here: research